Klingenstein Fields & Co »

Regeneron Pharmaceuticals shares owned by Klingenstein Fields & Co

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Klingenstein Fields & Co from 13F filings

Historical chart of Klingenstein Fields & Co investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Klingenstein Fields & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Klingenstein Fields & Co

Quarter filed Position value Share count Share price at filing
2024-03-31 $553k 575 962.49
2023-12-31 $505k 575 878.29
2023-09-30 $474k 576 822.96
2023-06-30 $414k 576 718.54
2023-03-31 $473k 575 821.67
2022-12-31 $415k 575 721.49
2022-09-30 $396k 575 688.70
2022-06-30 $340k 575 591.30
2022-03-31 $402k 575 699.13
2021-12-31 $505k 800 631.25
2021-09-30 $536k 885 605.65
2021-06-30 $494k 885 558.19
2021-03-31 $419k 885 473.45
2020-12-31 $246k 510 482.35
2017-03-31 $752k 1.9k 387.63
2016-12-31 $697k 1.9k 366.84